DRL's Andhra Pradesh facility gets 3 observations from USFDA 0 24.08.2024 12:20 Business Standard Dr Reddy's Laboratories said that the US drug regulator has issued Form 483, with three observations after inspecting its Andhra Pradesh manufacturing facility. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
